VJVincent Jecko

Vincent Jecko

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Vincent Jecko has a total of 153 co-authors. Here are the top co-authors by number of shared publications:

  • Charles Champeaux-Depond

    Department of Neurosurgery, Clairval Private Hospital, 317 Bd du Redon, 13 009 Marseille, France

    6 shared publications
  • Jean-Rodolphe Vignes

    Centre Hospitalier Territorial Gaston-Bourret

    5 shared publications
  • Joconde Weller

    Agence régionale de santé, Saint Denis, France

    4 shared publications
  • Paul Roblot

    Neurosurgery Unit, Médipôle Koutio, Centre Hospitalier Territorial de Nouvelle-Calédonie, 98 835, Dumbéa-Sur-Mer, New Caledonia

    4 shared publications
  • Dominique Liguoro

    Neurosurgery Department A, University Hospital of Bordeaux, Place Amélie Raba-Léon, 33076 Bordeaux, France; University Hospital of Bordeaux, Place Amélie Raba-Léon, 33076 Bordeaux, France; Laboratory of Anatomy, University of Bordeaux, 33000 Bordeaux, France; Department of Applied Surgical Research and Techniques (DETERCA), University of Bordeaux, Bordeaux, France

    3 shared publications
  • M. Rué

    Neurosurgery A Unit, University of Bordeaux-Segalen, Pellegrin University Hospital, Bordeaux, France

    3 shared publications

Latest Publications

  • Open Access

    No Impact of Psychosocial Stress on Glioblastoma Development

    by Durrechou Q, Engelhardt J, Jecko V, Planchon C, Larroquette M, Bronnimann C

    Purpose: Psychosocial stress represents an important source of questions in the potential implication of origin of cancer. The aim of the study was to assess stress prevalence prior to diagnosis of wild-type IDH glioblastoma. Methods: This prospective single-center study enrolled consecutive new cases of wild-type IDH glioblastoma diagnosed between December 2019 and March 2021 at the University Hospital of Bordeaux. A standardized patient self-assessment stress questionnaire explored both the presence of stressor exposure and the intensity of patient stress level prior to the diagnosis. Four groups were included: high stressors/high stress, high stressors/low stress, low stressors/low stress and low stressors/high stress. Patient characteristics were collected. Statistical analysis was based on the Chi-square test and the Kaplan-Meier survival estimator. Results: Sixty-four patients with a median age of 66 years were included. Glioblastoma involved predominantly the frontal lobe (39%). Thirty-six patients (56.3%) presented a low stressor/low stress profile. Stress corresponded mainly to the death of a loved one or to family health problems. Among working professionals, 20 patients (67.5%) reported low-intensity work stress. A history of depression was found in 30%. Progression-free survival at 6 months was 45.3% and median overall survival was estimated to be 16.5 months. Level and presence of stress did not differ based on location of tumour. No association was found between stress and tumour progression or overall survival. Conclusion: A majority of patients in this study had low exposure to stressors as well as low stress level. Psychological stress did not seem to favour the emergence of glioblastoma or survival.

  • Microsurgery of Cerebellopontine Angle Tumors

    by Vincent Darrouzet, Valérie Franco, Alix Ribadeau-Dumas, Yasmine Berrada, Vincent Jecko, Dominique Liguoro

  • Open Access

    Survival After Newly-Diagnosed High-Grade Glioma Surgery: What Can We Learn From the French National Healthcare Database?

    by Charles Champeaux Depond, Luc Bauchet, Dahmane Elhairech, Philippe Tuppin, Vincent Jecko, Joconde Weller, Philippe Metellus

    Champeaux Depond C, et al. Brain Tumor Res Treat. 2024 Jul;12(3):162-171. https://doi.org/10.14791/btrt.2024.0020


  • When to discharge patients following a neuronavigation-assisted brain biopsy for supratentorial lesion? A single-center experience

    by Lorenzo Mongardi, Yaniss Belaroussi, Mohammed Kara, Laetitia Le Petit, Edouard Gimbert, Gaëlle Kerdiles, Hugues De Courson, Thomas Wavasseur, Dominique Liguoro, Jean-Rodolphe Vignes, et al.


  • Recurrent high grade glioma surgery with carmustine wafers implantation: a long-term nationwide retrospective study

    by Charles Champeaux-Depond, Vincent Jecko, Joconde Weller, Panayotis Constantinou, Philippe Tuppin, Philippe Metellus

    Purpose Widespread use of carmustine wafers (CW) to treat high-grade gliomas (HGG) has been limited by uncertainties about its efficacy. To assess the outcome of patients after recurrent HGG surgery with CW implantation and, search for associated factors. Methods We processed the French medico-administrative national database between 2008 and 2019 to retrieve ad hoc cases. Survival methods were implemented. Results 559 patients who had CW implantation after recurrent HGG resection at 41 different institutions between 2008 and 2019 were identified. 35.6% were female and, median age at HGG resection with CW implantation was 58.1 years, IQR [50–65.4]. 520 patients (93%) had died at data collection with a median age at death of 59.7 years, IQR [51.6–67.1]. Median overall survival (OS) was 1.1 years, 95%CI[0.97–1.2], id est 13.2 months. Median age at death was 59.7 years, IQR [51.6–67.1]. OS at 1, 2 and 5 years was 52.1%, 95%CI[48.1–56.4], 24.6%, 95%CI[21.3–28.5] & 8%, 95%CI[5.9–10.7] respectively. In the adjusted regression, bevacizumab given before CW implantation, (HR = 1.98, 95%CI[1.49–2.63], p < 0.001), a longer delay between the first and the second HGG surgery (HR = 1, 95%CI[1–1], p < 0.001), RT given before and after CW implantation (HR = 0.59, 95%CI[0.39–0.87], p = 0.009) and TMZ given before and after CW implantation (HR = 0.81, 95%CI[0.66–0.98], p = 0.034) remained significantly associated with a longer survival. Conclusion OS of patients with recurrent HGG that underwent surgery with CW implantation is better in case of prolonged delay between the two resections and, for the patients who had RT and TMZ before and after CW implantation.


  • Newly Diagnosed High-Grade Glioma Surgery with Carmustine Wafers Implantation. A Long-Term Nationwide Retrospective Study

    by Charles Champeaux-Depond, Vincent Jecko, Joconde Weller, Panayotis Constantinou, Philippe Tuppin, Philippe Metellus


  • Skin landmarks as ideal entry points for ventricular drainage, a radiological study

    by Paul Roblot, Etienne Lefevre, Romain David, Pier-Luka Pardo, Lorenzo Mongardi, Laurent Denat, Thomas Tourdias, Dominique Liguoro, Vincent Jecko, Jean-Rodolphe Vignes

    Purpose Ventricular drainage remains a usual but challenging procedure for neurosurgical trainees. The objective of the study was to describe reliable skin landmarks for ideal entry points (IEPs) to catheterize brain ventricles via frontal and parieto-occipital approaches. Methods We included 30 subjects who underwent brain MRI and simulated the ideal catheterization trajectories of lateral ventricles using anterior and posterior approaches and localized skin surface IEPs. The optimal frontal target was the interventricular foramen and that for the parieto-occipital approach was the atrium. We measured the distances between these IEPs and easily identifiable skin landmarks. Results The frontal IEP was localized to 116.8 ± 9.3 mm behind the nasion on the sagittal plane and to 39.7 ± 4.9 mm lateral to the midline on the coronal plane. The ideal catheter length was estimated to be 68.4 ± 6.4 mm from the skin surface to the interventricular foramen. The parieto-occipital point was localized to 62.9 ± 7.4 mm above the ipsilateral tragus on the coronal plane and to 53.1 ± 9.1 mm behind the tragus on the axial plane. The ideal catheter length was estimated to be 48.3 ± 9.6 mm. Conclusion The IEP for the frontal approach was localized to 11 cm above the nasion and 4 cm lateral to the midline. The IEP for the parieto-occipital approach was 5.5 cm behind and 6 cm above the tragus. These measurements lightly differ from the classical descriptions of Kocher’s point and Keen’s point and seem relevant to neurosurgical practice while using an orthogonal insertion.


  • Surgical or Endovascular Treatment of MCA Aneurysms: An Agreement Study

    by W. Boisseau, T.E. Darsaut, R. Fahed, J.M. Findlay, R. Bourcier, G. Charbonnier, S. Smajda, J. Ognard, D. Roy, F. Gariel, et al.

    BACKGROUND AND PURPOSE: MCA aneurysms are still commonly clipped surgically despite the recent development of a number of endovascular tools and techniques. We measured clinical uncertainty by studying the reliability of decisions made for patients with middle cerebral artery (MCA) aneurysms. MATERIALS AND METHODS: A portfolio of 60 MCA aneurysms was presented to surgical and endovascular specialists who were asked whether they considered surgery or endovascular treatment to be an option, whether they would consider recruitment of the patient in a randomized trial, and whether they would provide their final management recommendation. Agreement was studied using κ statistics. Intrarater reliability was assessed with the same, permuted portfolio of cases of MCA aneurysm sent to the same specialists 1 month later. RESULTS: Surgical management was the preferred option for neurosurgeons (n = 844/1320; [64%] responses/22 raters), while endovascular treatment was more commonly chosen by interventional neuroradiologists (1149/1500 [76.6%] responses/25 raters). Interrater agreement was only “slight” for all cases and all judges (κ = 0.094; 95% CI, 0.068–0.130). Agreement was no better within specialties or with more experience. On delayed requestioning, 11 of 35 raters (31%) disagreed with themselves on at least 20% of cases. Surgical management and endovascular treatment were always judged to be a treatment option, for all patients. Trial participation was offered to patients 65% of the time. CONCLUSIONS: Individual clinicians did not agree regarding the best management of patients with MCA aneurysms. A randomized trial comparing endovascular with surgical management of patients with MCA aneurysms is in order.


  • Open Access

    Functional Outcome After Spinal Meningioma Surgery. A Nationwide Population-Based Study

    by Charles Champeaux-Depond, Nicolas Penet, Joconde Weller, Jean-Charles Le Huec, Vincent Jecko

    Objective: To describe and analysed the functional outcome (FO) after spinal meningioma (SM) surgery.Methods: We processed the système national des données de santé (SNDS) i.e. , the French national administrative medical database to retrieve appropriate cases. We analysed the International Classification of Diseases 10 codes to assess the FO. Logistic models were implemented to search for variables associated with a favourable FO i.e. , a patient being independent at home without disabling symptom.Results: A total of 2,844 patients were identified of which 79.1% were female. Median age at surgery was 66 years, interquartile range (IQR) (56–75). Ninety-five point nine percent of the SMs were removed through a posterior ± lateral approach and 0.7% need an associated stabilisation. Benign meningioma represented 92.9% and malignant 2.1%. Median follow-up was 5.5 years, IQR (2.1–8), and at data collection 9% had died. The FO was good and increased along the follow-up: 84.3% of the patients were alive and had not associated symptoms at one year, 85.9% at 2 and 86.8% at 3 years. Nonetheless, 3 years after the surgery 9.8% of the alive patients still presented at least one disabling symptom of which 2.7% motor deficit, 3.3% bladder control problem, and 2.5% gait disturbance. One point seven percent were care-provider dependent and 2.1% chair or bedfast. In the multivariable logistic regression an older age at surgery (odds ratio [OR], 0.37; 95% confidence interval [CI], 0.29–0.47, p < 0.001), a high level of comorbidities (OR, 0.71; 95% CI, 0.66–0.75, p < 0.001), and an aggressive tumor (OR, 0.49; 95% CI, 0.33–0.73; p < 0.001) were associated with a worse FO.Conclusion: FO after meningioma surgery is favourable but, may be impaired for older patients with a high level of comorbidities and aggressive tumor.